You are here

IPOs

AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation

Fierce Biotech

Mon, 12/7/20 - 10:37 am

Seer, a developer of protein analysis tools, prices upsized IPO at $19, above the range

Renaissance Capital

Fri, 12/4/20 - 10:56 am

protein analysis

Sigilon Therapeutics prices upsized IPO at $18

Seeking Alpha

Fri, 12/4/20 - 10:54 am

endocrine diseases

rare blood diseases

Kinnate Biopharma upsizes IPO and prices above range at $20 a share

Marketwatch

Fri, 12/4/20 - 10:53 am

Kinnate Biopharma

small molecule kinase inhibitors

Solid tumor biotech Silverback Therapeutics ups proposed deal size by 56% ahead of $195 million IPO

NASDAQ

Thu, 12/3/20 - 11:00 am

Silverback Therapeutics

Overnight fortunes are being made in biotech these days — and it's both encouraging and more than a little bit scary

Endpoints

Tue, 11/24/20 - 10:43 am

4DMT shoots for a $75M IPO, its second attempt to go public with its gene therapy vector programs

Endpoints

Wed, 11/18/20 - 12:12 pm

4D Molecular Therapeutics

Seattle biotech firm Silverback Therapeutics aims for $100M IPO

Seattle Times, WA

Wed, 11/11/20 - 11:13 am

Silverback Therapeutics

RemeGen grabs one of the world's largest ever biotech IPOs

Fierce Biotech

Mon, 11/9/20 - 11:10 am

JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China

Endpoints

Wed, 11/4/20 - 10:30 am

JW Therapeutics

Juno Therapeutics

Inhibikase Therapeutics slahes deal size ahead of IPO

Fierce Biotech

Wed, 11/4/20 - 10:27 am

Inhibikase Therapeutics

Atea, riding interest in COVID-19 drugs, pulls off one of 2020's top biotech IPOs

BioPharma Dive

Fri, 10/30/20 - 10:30 am

Atea Pharmaceuticals

small molecule drugs

RemeGen readies $514M IPO as HKEX adds jewel to the crown

Endpoints

Wed, 10/28/20 - 10:43 am

A record number of biotechs are going public. Here's how they're performing.

BioPharma Dive

Mon, 10/26/20 - 11:10 pm

Foghorn hits Nasdaq in $120M debut as the biotech IPO boom shows no sign of slowing

Endpoints

Fri, 10/23/20 - 11:57 am

Foghorn Therapeutics

chromatin regulatory system

Eargo soars after announcing $141.3M IPO

Mass Device

Mon, 10/19/20 - 10:45 am

hearing devices

The two months in 1980 that shaped the future of biotech

Stat

Sat, 10/17/20 - 11:49 pm

Four biotechs and a Matthew Roden-led SPAC price IPOs, raising a combined $528M

Endpoints

Fri, 10/16/20 - 12:16 pm

Praxis Precision Medicines

Tarsus Pharmaceuticals

Aligos Therapeutics

Kiromic Biopharma

Tumeric Acquisition

It’s Raining Biotech SPACs!

Forbes

Thu, 10/15/20 - 11:07 am

Codiak lands on Wall Street in second shot at IPO, raises $83M

Endpoints

Thu, 10/15/20 - 10:59 am

Codiak Biosciences

Pages